WeVote

Bill

Bill

A 1713

Requires health insurance coverage for lymphedema

2025 Regular Session Introduced by Charles Lavine and 4 co-sponsors

Requires health insurance plans to cover lymphedema services and treatments, aiming to improve access and reduce patients’ out-of-pocket costs.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 1713

Summary of Assembly Bill A 1713 – Requires health insurance coverage for lymphedema

Overview

  • Bill number and title: A 1713, Requires health insurance coverage for lymphedema
  • Purpose (as stated by title): Mandate health insurance coverage for lymphedema, ensuring access to necessary diagnosis, treatment, and management of the condition.
  • Current status: Referred to the Insurance Committee.
  • Introduced: January 14, 2025

Legislative Action

  • 2025-01-14: REFERRED TO INSURANCE
  • 2025-01-14: REFERRED TO INSURANCE
    • The duplicate entry indicates the bill was referred to the Insurance Committee on that date and, as of the provided materials, has not advanced further.

Sponsors

  • Primary sponsor: Linda Rosenthal
  • Cosponsors: Angelo Santabarbara, Charles Lavine, Phil Steck, Steven Raga

Related Legislation

  • Prior-session related bills:
    • A 436
    • A 8363
    • A 2271
    • A 2816
    • A 491
    • A 1876

What the bill would do (based on the title and available information)

  • The bill would require health insurance plans to cover lymphedema-related services and treatments.
  • The exact scope of covered services, cost-sharing requirements (e.g., deductibles, co-pays), eligibility criteria, durable medical equipment (e.g., compression garments, pumps), treatment modalities (e.g., therapy, decongestive therapy), and any exemptions or carve-outs are not specified in the provided materials.
  • As introduced, the bill signals an intent to ensure insurers provide coverage for lymphedema care to improve access and reduce potential out-of-pocket costs for patients.

Potential impact

  • For patients: Improved access to coverage for lymphedema diagnosis and treatment, potentially lowering out-of-pocket expenses and reducing financial barriers to care.
  • For insurers/plans: May require changes to coverage policies, documentation, and cost-sharing structures to align with the bill’s requirements once provisions are specified.
  • Timing: With the current status as “Referred to Insurance,” further action (hearings, amendments, floor votes) would determine any implementation timeline and effective dates.

Notes and next steps

  • The bill’s text is not provided in the materials, so specific provisions, eligible services, and implementation details are not available here.
  • To accurately assess the substantive provisions and impact, obtain the full bill text and any fiscal notes, analyses, or sponsor memos.
  • Monitor Insurance Committee activity and any amendments or companion bills (e.g., related A-number bills from prior sessions) for developments.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.